Efficacy and Safety of Azimilide in the Prophylactic Treatment of Patients With Atrial Fibrillation.

NCT00035464 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

431

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Azimilide Dihydrochloride
DRUG: Placebo

Sponsor

Forest Laboratories